Microcarrier-Based Culture of Human Pluripotent Stem-Cell-Derived Retinal Pigmented Epithelium

Dry age-related macular degeneration (AMD) is estimated to impact nearly 300 million individuals globally by 2040. While no treatment options are currently available, multiple clinical trials investigating retinal pigmented epithelial cells derived from human pluripotent stem cells (hPSC-RPE) as a c...

Descripción completa

Detalles Bibliográficos
Autores principales: Faynus, Mohamed A., Bailey, Jeffrey K., Pennington, Britney O., Katsura, Mika, Proctor, Duncan A., Yeh, Ashley K., Menon, Sneha, Choi, Dylan G., Lebkowski, Jane S., Johnson, Lincoln V., Clegg, Dennis O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311890/
https://www.ncbi.nlm.nih.gov/pubmed/35877348
http://dx.doi.org/10.3390/bioengineering9070297

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311890/
https://www.ncbi.nlm.nih.gov/pubmed/35877348
http://dx.doi.org/10.3390/bioengineering9070297

Ejemplares similares